Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 8 recruiting now early-phase tilt small index

Deafness: early-phase trial registry

8 of 12 indexed Deafness trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,429 of 28,707 conditions by registered trial count.

12 US clinical trials · 8 currently recruiting · #1,429 of 28,707 conditions by registered trial count

Deafness: 12 US clinical trials tracked, 8 recruiting.

Deafness is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is NYU Langone Health, running 3 of these trials.

Enrollment posture brief

Registry condition deafness

OPEN 8 | RECR 67% | LATE 0 | EARLY 1 | RANK #1429 | SPON 3

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Deafness (this)67%Acute Myeloid Leukemia in Re41.7%Adenocarcinoma of the Rectum41.7%Adherence, Patient16.7%Accelerated Phase Chronic My0%
Open-enrollment share among volume-matched conditions near Deafness

Deafness lists 8 open slots (67% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Deafness on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Deafness is recruiting above its size-band peers.

    8 of 12 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Deafness research.

    NYU Langone Health accounts for 3 of 12 trials (25%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Typical Deafness enrolment sits around 190 participants.

    Median target enrolment is 190 among the 12 trials that report a genuine target (sentinel values excluded). 5 of those (41.7%) plan for fewer than 100 participants.

  4. Deafness research is mostly interventional.

    10 interventional and 2 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Open and recent trials

12 total, page 1 of 1

RECRUITING 5,000 participants

Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study

Washington University School of Medicine

NCT02841553

RECRUITING 600 participants

Collection of Clinical Data and Specimens for Research in Hearing, Balance, Taste, Smell, Voice, Speech, and Language Disorders.

National Institute on Deafness and Other Communication Disorders (NIDCD)

NCT05670496

RECRUITING NA 200 participants

Perceptual Consequences of Cochlear Implant Electrode-neuron Interfaces

Massachusetts Eye and Ear Infirmary

NCT05867173

RECRUITING NA 200 participants

Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants

NYU Langone Health

NCT05810220

RECRUITING NA 190 participants

Novel Coding Strategies for Children With Cochlear Implants

NYU Langone Health

NCT05203302

RECRUITING NA 48 participants

Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy

Massachusetts Eye and Ear Infirmary

NCT06960616

RECRUITING NA 40 participants

Word Learning in Deaf Children Using Eye-tracking and Behavioral Measures

Boston University Charles River Campus

NCT05993832

RECRUITING NA 30 participants

Auditory-Cognitive Training to Optimize Outcomes for Older CI Users

Gallaudet University

NCT05176561

ACTIVE NOT RECRUITING NA 120 participants

Hearing Program in Primary Care

NYU Langone Health

NCT05943509

ACTIVE NOT RECRUITING NA 40 participants

Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL

University of Connecticut

NCT04988451

COMPLETED Phase 1 303 participants

Outcomes In Children With Developmental Delay And Deafness

Stanford University

NCT01256229

COMPLETED NA 20 participants

Aural Rehabilitation for Cochlear Implant Users Via Telerehab Technology

Gallaudet University

NCT03157492

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Deafness records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

cochlear implantation Device
1 trials
Cognitive Training Group Behavioral
1 trials
Aural Rehabilitation Group Behavioral
1 trials
ASL Services Behavioral
1 trials
Alternative rehabilitation strategies Behavioral
1 trials
hearing aids Device
1 trials
Population mean mapping Other
1 trials
Changes in traditional follow-up Other
1 trials

US sites by state

Facility locations filed on Deafness trials. A trial with sites in several states counts in each.

New York 5 trials
Massachusetts 3 trials
Maryland 2 trials
Texas 1 trials
Tennessee 1 trials
Ohio 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Deafness page

12 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Deafness condition card totals 12 registered trials; most-linked intervention cochlear implantation; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.